Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 40 studies | 62% ± 29% | |
endothelial cell of lymphatic vessel | 23 studies | 70% ± 22% | |
capillary endothelial cell | 17 studies | 68% ± 25% | |
endothelial cell of artery | 15 studies | 70% ± 25% | |
fibroblast | 14 studies | 35% ± 20% | |
vein endothelial cell | 13 studies | 69% ± 23% | |
endothelial cell of vascular tree | 12 studies | 56% ± 25% | |
pericyte | 11 studies | 35% ± 27% | |
myofibroblast cell | 7 studies | 23% ± 4% | |
connective tissue cell | 7 studies | 35% ± 16% | |
mesothelial cell | 5 studies | 41% ± 20% | |
glomerular endothelial cell | 4 studies | 90% ± 6% | |
smooth muscle cell | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 2114.41 | 646 / 653 | 98% | 73.43 | 595 / 605 |
breast | 100% | 4578.73 | 459 / 459 | 97% | 73.67 | 1087 / 1118 |
prostate | 98% | 1208.42 | 240 / 245 | 98% | 37.39 | 490 / 502 |
lung | 100% | 4490.89 | 578 / 578 | 93% | 36.75 | 1074 / 1155 |
ovary | 93% | 837.14 | 168 / 180 | 95% | 40.16 | 410 / 430 |
uterus | 99% | 1865.68 | 169 / 170 | 88% | 41.50 | 406 / 459 |
bladder | 95% | 1306.24 | 20 / 21 | 91% | 31.36 | 461 / 504 |
kidney | 98% | 1385.92 | 87 / 89 | 88% | 86.96 | 795 / 901 |
esophagus | 86% | 1129.19 | 1241 / 1445 | 95% | 40.24 | 173 / 183 |
adrenal gland | 87% | 693.84 | 225 / 258 | 93% | 59.61 | 213 / 230 |
intestine | 91% | 988.24 | 878 / 966 | 88% | 31.15 | 465 / 527 |
brain | 72% | 533.72 | 1909 / 2642 | 100% | 61.13 | 705 / 705 |
stomach | 78% | 692.74 | 281 / 359 | 94% | 50.07 | 268 / 286 |
skin | 67% | 936.30 | 1208 / 1809 | 92% | 49.81 | 433 / 472 |
pancreas | 17% | 93.15 | 57 / 328 | 98% | 48.88 | 174 / 178 |
liver | 12% | 70.47 | 27 / 226 | 89% | 29.76 | 362 / 406 |
adipose | 100% | 4772.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.93 | 1 / 1 |
spleen | 98% | 1084.34 | 237 / 241 | 0% | 0 | 0 / 0 |
heart | 98% | 1511.48 | 846 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 31.55 | 41 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 23.89 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 81% | 23.29 | 65 / 80 |
blood vessel | 79% | 949.00 | 1060 / 1335 | 0% | 0 | 0 / 0 |
muscle | 72% | 478.40 | 580 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 4.14 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_2000352 | Biological process | negative regulation of endothelial cell apoptotic process |
GO_0031623 | Biological process | receptor internalization |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0034333 | Biological process | adherens junction assembly |
GO_1990410 | Biological process | adrenomedullin receptor signaling pathway |
GO_0007507 | Biological process | heart development |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0043116 | Biological process | negative regulation of vascular permeability |
GO_0008217 | Biological process | regulation of blood pressure |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0001570 | Biological process | vasculogenesis |
GO_0006886 | Biological process | intracellular protein transport |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0097084 | Biological process | vascular associated smooth muscle cell development |
GO_0002040 | Biological process | sprouting angiogenesis |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
GO_0070830 | Biological process | bicellular tight junction assembly |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_2001214 | Biological process | positive regulation of vasculogenesis |
GO_0015031 | Biological process | protein transport |
GO_0035924 | Biological process | cellular response to vascular endothelial growth factor stimulus |
GO_0006816 | Biological process | calcium ion transport |
GO_0070831 | Biological process | basement membrane assembly |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005764 | Cellular component | lysosome |
GO_0009986 | Cellular component | cell surface |
GO_0005737 | Cellular component | cytoplasm |
GO_1903143 | Cellular component | adrenomedullin receptor complex |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0015026 | Molecular function | coreceptor activity |
GO_1990409 | Molecular function | adrenomedullin binding |
GO_0001605 | Molecular function | adrenomedullin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RAMP2 |
Protein name | Receptor activity modifying protein 2 Receptor activity-modifying protein 2 (Calcitonin-receptor-like receptor activity-modifying protein 2) (CRLR activity-modifying protein 2) |
Synonyms | |
Description | FUNCTION: Transports the calcitonin gene-related peptide type 1 receptor (CALCRL) to the plasma membrane. Acts as a receptor for adrenomedullin (AM) together with CALCRL. . |
Accessions | K7EKQ3 ENST00000253796.10 [O60895-1] K7ENJ8 ENST00000588928.1 K7EPN3 ENST00000589683.5 O60895 ENST00000588576.1 ENST00000587142.5 [O60895-2] |